More Canadians to benefit from personalized cancer treatment

August 14, 2015

Personalized cancer treatment requires complex clinical laboratory testing to determine a tumour’s genetic profile. The Princess Margaret Cancer Centre, a leader in providing this testing for its patients, and LifeLabs Medical Laboratory Services have begun working together to expand this testing capacity to more Canadians. The Princess Margaret Cancer Centre (PMCC) has teamed up with…

Read More

Rising prices for new targeted therapeutics threatens their own success

August 14, 2015

One cancer drug alone could wipe out Canada’s total budget of $12B for prescription drugs. Can this last? Drug companies bringing out new targeted therapies for rare disorders are asking, and getting, eye-popping prices. Examples include Kalydeco® for one type of Cystic Fibrosis, reported to cost CAD$300,000 per year, or the recently marketed Solaris® for…

Read More

Can personalized cancer care be cost-effective?

August 14, 2015

A study of personalized cancer care in action found that this approach not only saved money but resulted in better outcomes. Such personalized cancer treatment is available here in Ontario. A small study by Intermountain Healthcare, in Salt Lake City, compared the costs of using personalized medicine in cancer patients with late stage, metastatic disease….

Read More

Panel finds that access to health data should be a priority

July 16, 2015

An expert panel formed by the Council of Canadian Academies (CCA) has made five recommendations for improving access to health and health-related data while balancing privacy. The CCA was tasked by Canadian Institutes of Health Research (CIHR) to review the current state of knowledge regarding timely access to health and “health-related” (i.e. social determinants of…

Read More